-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170

Benzinga·11/05/2026 23:31:45
Listen to the news
JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $152 to $170.